20 June 2013
Keywords: myotrophin, nda, filed, usa, cephalon, chiron, approval
Article | 17 February 1997
Cephalon and Chiron have filed for approval of Myotrophin (mecasermin;insulin-like growth factor-1) in the USA for the treatment of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 February 1997
24 February 1997
19 June 2013
© 2013 thepharmaletter.com